Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
Our newest symposium runs virtually on Dec. 10-11, 2021. After one day of scientific and clinical innovations, back by popular demand is a day devoted to managing heart failure in primary care settings. Register here.
The Centre’s first-ever virtual symposium was held Dec. 4-5, 2020. It features, for the second straight year, a research-focused day and a day devoted to managing heart failure in primary care.
The fourth annual Ted Rogers Centre Heart Failure Symposium, May 3-4, 2019 in Toronto was held held in conjunction with the Heart & Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research’s Michael J. Sole Annual Cardiovascular Scientific Day.
With nearly 400 attendees, this continued to be Canada’s largest conference on heart failure, where national and international experts will explore cutting-edge innovations in precision medicine, basic and translational research, molecular imaging, bioengineering, and much more.
At Canada’s largest meeting devoted to heart failure, the Ted Rogers Centre and Canadian Heart Failure Society united to host Heart Failure Update for a second consecutive year.
The event drew more than 500 participants and featured national and international heart failure experts. With a bench-to-bedside makeup, focused on the latest clinical advances for the practicing clinician and nurse while exploring novel basic and translational science in key areas that have a major impact on heart failure care. For videos of presentations, please see our YouTube channel.
The Canadian Heart Failure Society and the Ted Rogers Centre for Heart Research united to co-host Canada’s largest meeting devoted to heart failure. This special event offered the latest information for the practising clinician and nurse, and a simultaneous stream focused on investigative research – truly bench to bedside.
Sessions featured an interactive roster of expert plenaries, case-based panel discussions, workshops and debates targeted at health-care professionals and investigators whose focus is improved heart failure treatment and prevention.
Our first major international conference launched in Toronto in May 2016. The Ted Rogers Centre for Heart Research Scientific Symposium united the cardiovascular community in southern Ontario and beyond to participate in advanced concepts and conversations around heart failure.
This two-day event featured leading experts across multiple disciplines including keynote speakers Dr. Hugh Watkins (University of Oxford, at left), Dr. Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute) and Dr. Adrian Hernandez (Duke University).
